Rational use of Medicines and other Health Technologies

The Conference of Experts on the Rational Use of Drugs, convened by the World Health Organization in Nairobi in 1985, defined rational use as follows: Rational use of drugs requires that patients receive medicines appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, and at the lowest cost to them and their community.

Pharmacists

Pharmaceutical education throughout the Americas is responsible for preparing students to begin the practice of pharmacy as vital members of the health care team with all the required skills and knowledge.

The Pharmaceutical Conferences on Pharmaceutical Education have been held since 1990 each three years to promote the collaboration among Colleges, Schools and Departments of Pharmacy in the Americas.


Pan American Conference on Pharmaceutical Education (PCFE)

The PCFE have been held since 1990, with the participation of delegates from the Region of the Americas, to promote cooperation among pharmacy schools in the Americas.

- X Pan American Conference on Pharmaceutical Education, October 25-27, Antigua, Guatemala, 2016

IX Pan American Conference on Pharmaceutical Education, 2014

- VIII Pan American Conference on Pharmaceutical Education (PCFE), 2012

- VII Pan American Conference on Pharmaceutical Education, Puerto Alegre, 2010: Conference Agenda

- VI Pan American Conference on Pharmaceutical Education, Montevideo, Uruguay 2008:

-  V Pan American Conference on Pharmaceutical Education, Miami, USA 2002

-  IV Pan American Conference on Pharmaceutical Education, Santiago, Chile 1999

-  III Pan American Conference on Pharmaceutical Education, Buenos Aires, Argentina 1996

- II Pan American Conference on Pharmaceutical Education, Guerrero, Mexico 1993

- I Pan American Conference on Pharmaceutical Education, Miami, USA 1990

Scientific and Technical Material

Links of Interest


In the Americas, during the II Pan American Conference on Drug Regulatory Harmonization (1999) a panel discussion was held on medicines counterfeiting during which the WHO guidelines to combat drug counterfeiting were presented and it was concluded that:

  1. Falsification of medicine is a problem that exists in varying degrees in most of the countries of the region and in some countries strong measures have been taken to reduce the problem;
  2. The guidelines for the development of the fight against counterfeit drugs is a good tool that can be used by the countries;
  3. Most of the countries lack up-to-date legislation that would make it possible to address this crime and enforce exemplary penalties;
  4. Addressing the problem requires that the health authorities coordinate their actions with the police and judicial authorities and with producers and distributors, and uncontrolled proliferation of distribution channels and pharmacies in some countries can affect the existence of this crime.

Mandates and Strategies

Communication Materials

Scientific and Technical Material

Links of interest


Get well soon iconThe World Health Organization (WHO) implemented a strategy on medicines and established Ethical Criteria for Medicinal Drug Promotion, which support and promote public health protection through the rational use of medicines.

In view of the influence that promoting, advertising, and publicizing medicines has on those who take them and on their consumption patterns, as well as the subsequent impact on health systems and the harmful health outcomes that this can produce both individually and collectively, it has become necessary to improve, expand, and define ethical criteria to strengthen public health protection and safety concerning the risks associated with the use of medicines.

Within this framework, it is especially necessary to raise awareness and protect the most vulnerable segments of the population, such as children, the elderly, pregnant women, and the chronically ill.

In its regulatory activities related to promoting, publicizing, and advertising medicines, it is recommended that the Pan American Network for Medicine Regulatory Harmonization (PANDRH) members be guided by the Ethical Criteria supported by and consistent with those already established by the World Health Organization, taking their own national policies and legislation into consideration.


Scientific and Technical Material

Strategic Partners

Information Resources



WHO defines Pharmacovigilance as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems.



Scientific and Technical Material

WHO pharmacovigilance indicators

Reporting and learning Systems for Medication

Pharmacovigilance TB

pdf

Links of Interest

PAHO/WHO

External